Sedana Medical AB (publ) Stock price
Equities
SEDANA
SE0015988373
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
23.52 SEK | +0.60% | +13.62% | +25.78% |
Nov. 22 | Sedana Medical’s Sedaconda Gains Data Exclusivity, Market Protection in Europe | MT |
Nov. 22 | Sedana Medical Secures Data Exclusivity and Market Protection for Sedaconda Until 2031 | CI |
Sales 2023 * | 149M 14.33M | Sales 2024 * | 196M 18.86M | Capitalization | 2.32B 223M |
---|---|---|---|---|---|
Net income 2023 * | -43M -4.13M | Net income 2024 * | -50M -4.8M | EV / Sales 2023 * | 13,9x |
Net cash position 2023 * | 249M 23.89M | Net cash position 2024 * | 119M 11.46M | EV / Sales 2024 * | 11,2x |
P/E ratio 2023 * | -52,5x | P/E ratio 2024 * | -44,6x | Employees | 83 |
Yield 2023 * | - | Yield 2024 * | - | Free-Float | 63.27% |
More Fundamentals
* Assessed data
More news
More press releases
More news
1 day | +3.12% | ||
1 week | +15.94% | ||
Current month | +19.05% | ||
1 month | +29.80% | ||
3 months | +27.66% | ||
6 months | -25.00% | ||
Current year | +28.34% |
1 week
20.40
24.12

1 month
16.42
24.12

Current year
15.97
34.50

1 year
15.97
34.50

3 years
15.97
111.00

5 years
15.97
111.00

10 years
5.00
111.00

Managers | Title | Age | Since |
---|---|---|---|
Johannes Doll
CEO | Chief Executive Officer | 42 | 2021 |
Johan Spetz
DFI | Director of Finance/CFO | - | 2022 |
Peter Fröberg
CTO | Chief Tech/Sci/R&D Officer | 52 | 2020 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 2013 | |
Hilde Furberg
BRD | Director/Board Member | 65 | - |
Director/Board Member | 48 | 2020 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 589 M€ | +3.03% | - | |
0.01% | 3 M€ | 0.00% | - | |
0.00% | 14,684 M€ | +10.27% | - | |
0.00% | 201 M€ | +11.36% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-08 | 23.52 | +0.60% | 89 810 |
23-12-07 | 23.38 | -0.09% | 91,895 |
23-12-06 | 23.4 | +4.93% | 491,213 |
23-12-05 | 22.3 | +5.89% | 102,571 |
23-12-04 | 21.06 | +1.74% | 144,093 |
Delayed Quote Nasdaq Stockholm, December 08, 2023 at 06:14 am EST
More quotes
Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company's main shareholders are board members, Linc AB and Magiola Consulting AB.
Calendar
2024-02-14
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
C-
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
23.38SEK
Average target price
43SEK
Spread / Average Target
+83.92%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.34% | 223 M $ | |
+43.25% | 192 M $ |